Author
Listed:
- Aaron Burberry
(Harvard University
Broad Institute of MIT and Harvard)
- Michael F. Wells
(Harvard University
Broad Institute of MIT and Harvard)
- Francesco Limone
(Harvard University
Broad Institute of MIT and Harvard
Royal Netherlands Academy of Arts and Sciences)
- Alexander Couto
(Harvard University
Broad Institute of MIT and Harvard)
- Kevin S. Smith
(Harvard University
Broad Institute of MIT and Harvard)
- James Keaney
(UCB Biopharma SPRL)
- Gaëlle Gillet
(UCB Biopharma SPRL)
- Nick Gastel
(Harvard University
Massachusetts General Hospital)
- Jin-Yuan Wang
(Harvard University
Broad Institute of MIT and Harvard)
- Olli Pietilainen
(Harvard University
Broad Institute of MIT and Harvard)
- Menglu Qian
(Harvard University
Broad Institute of MIT and Harvard
Harvard University)
- Pierce Eggan
(Harvard University
Broad Institute of MIT and Harvard)
- Christopher Cantrell
(Harvard University
Broad Institute of MIT and Harvard)
- Joanie Mok
(Harvard University
Broad Institute of MIT and Harvard)
- Irena Kadiu
(UCB Biopharma SPRL)
- David T. Scadden
(Harvard University
Massachusetts General Hospital)
- Kevin Eggan
(Harvard University
Broad Institute of MIT and Harvard
Harvard University)
Abstract
A hexanucleotide-repeat expansion in C9ORF72 is the most common genetic variant that contributes to amyotrophic lateral sclerosis and frontotemporal dementia1,2. The C9ORF72 mutation acts through gain- and loss-of-function mechanisms to induce pathways that are implicated in neural degeneration3–9. The expansion is transcribed into a long repetitive RNA, which negatively sequesters RNA-binding proteins5 before its non-canonical translation into neural-toxic dipeptide proteins3,4. The failure of RNA polymerase to read through the mutation also reduces the abundance of the endogenous C9ORF72 gene product, which functions in endolysosomal pathways and suppresses systemic and neural inflammation6–9. Notably, the effects of the repeat expansion act with incomplete penetrance in families with a high prevalence of amyotrophic lateral sclerosis or frontotemporal dementia, indicating that either genetic or environmental factors modify the risk of disease for each individual. Identifying disease modifiers is of considerable translational interest, as it could suggest strategies to diminish the risk of developing amyotrophic lateral sclerosis or frontotemporal dementia, or to slow progression. Here we report that an environment with reduced abundance of immune-stimulating bacteria10,11 protects C9orf72-mutant mice from premature mortality and significantly ameliorates their underlying systemic inflammation and autoimmunity. Consistent with C9orf72 functioning to prevent microbiota from inducing a pathological inflammatory response, we found that reducing the microbial burden in mutant mice with broad spectrum antibiotics—as well as transplanting gut microflora from a protective environment—attenuated inflammatory phenotypes, even after their onset. Our studies provide further evidence that the microbial composition of our gut has an important role in brain health and can interact in surprising ways with well-known genetic risk factors for disorders of the nervous system.
Suggested Citation
Aaron Burberry & Michael F. Wells & Francesco Limone & Alexander Couto & Kevin S. Smith & James Keaney & Gaëlle Gillet & Nick Gastel & Jin-Yuan Wang & Olli Pietilainen & Menglu Qian & Pierce Eggan & C, 2020.
"C9orf72 suppresses systemic and neural inflammation induced by gut bacteria,"
Nature, Nature, vol. 582(7810), pages 89-94, June.
Handle:
RePEc:nat:nature:v:582:y:2020:i:7810:d:10.1038_s41586-020-2288-7
DOI: 10.1038/s41586-020-2288-7
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:582:y:2020:i:7810:d:10.1038_s41586-020-2288-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.